Board Meetings
| Company | Meeting | Agenda | Details | Listed |
|---|---|---|---|---|
Financial ResultsFund RaisingOther Business | Unaudited Standalone and Consolidated Financial Results of the Bank for the quarter ended 30th June, 2026, Borrowing/ raising funds by issue of debt securities and to Consider convening the Annual General Meeting of the shareholders of the Bank. | |||
Financial Results | To consider and approve the Unaudited financial results for the period ended Jun 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial ResultsOther Business | To consider and approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026 and other business matters | |||
Fund RaisingOther Business | To consider a) Fixation of record date for reduction/cancellation and extinguishment of 95% existing Equity Shares held by the erstwhile promoters and existing public shareholders of the Company ( existing equity paid-up share capital ) pursuant to NCLT order and b) Issuance of equity shares on a to the prospective allottees in compliance with the NCLT Order read with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended from time to time c) other business matters. | |||
Financial ResultsDividend | Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that the next meeting of the Board of Directors of Wipro Limited ( the Company ) will be held over July 15-16, 2026 to consider and approve, inter alia:a) the condensed audited standalone and consolidated financial results of the Company under lndAS for the quarter ended June 30, 2026.b) the condensed audited consolidated financial results of the Company under IFRS for the quarter ended June 30, 2026.c) declaration of interim dividend, if any, for the financial year 2026-27.The financial results will be approved by the Board of Directors on July 16, 2026.It is further informed that the trading window for dealing in the securities of the Company is closed from June 16, 2026 till the close of July 18, 2026 (both days inclusive). | |||
Fund RaisingOther Business | To consider Fund Raising and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsFund Raising | To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsDividend | To consider and approve the financial results for the period ended Jun 30, 2026 and dividend | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsFund Raising | To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising | |||
Financial Results | To consider and approve the financial results for the period ended June 30, 2026 | |||
Financial Results | To consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of Turtlemint Fintech Solutions Limited ( the Company ) is scheduled to be held on Friday, July 17, 2026, inter-alia to consider, approve and take on record the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2026. | |||
Financial Results | To consider and approve the financial results for the period ended March 31, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsDividend | To consider and approve the financial results for the quarter ended Jun 30, 2026 and to consider the 1st Interim dividend for FY 2026-27. | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the unaudited standalone and consolidated financial results of the Bank for the quarter ended June 30, 2026 | |||
Financial Results | To inter-alia consider and approve the unaudited financial results (standalone and consolidated) for the quarter ending June 30, 2026 | |||
Fund Raising | This has reference to our earlier letter dated June 25, 2026. We wish to inform you that the Board of the Bank at its meeting scheduled on July 18, 2026, will also inter-alia consider the revision of fund raising limit by way of issuance of bonds/notes/offshore certificate of deposits in overseas markets. We request you to kindly take the above information on record and consider this disclosure as compliance under Regulations 29 & 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Financial Results | Rossari Biotech Ltd has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2026,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026. | |||
Financial ResultsFund Raising | To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising | |||
Other Business | To consider other business matters | |||
Financial Results | Intimation of the date of the Board Meeting for considering Un-audited Financial Results for the Quarter (Q1) ended June 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Other Business | To consider other business matters Approval Of Directors Report, Corporate Governance Report, Notice For Convening Of AGM, Fixation Of AGM Date, Book Closure Date. | |||
Financial Results | To consider and approve the Audited Financial results of the Company for the Yearly ended March 2026. | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | |||
Financial Results | To consider and approve the unaudited financial results for the period ended Jun 30, 2026 |
Board meetings explained
What is a board meeting intimation?
Does a scheduled board meeting mean the decision will happen?
How far in advance are board meetings announced?
Can a company change or cancel the meeting date?
Why does one meeting show several agenda items?
What does "Other business matters" mean?
How is this different from the corporate actions calendar?
What does the "Listed" date mean?
How often is this calendar updated?
About this calendar
This page tracks board meetings that NSE listed companies have intimated to the exchange in advance — the meeting date, and what the board has said it will consider. Agendas include quarterly and annual financial results, fund raising, dividends, buybacks, bonus issues, stock splits, voluntary delisting, and general business. Where a company has filed a description of the business to be transacted, it is shown in its own words rather than summarised.
A scheduled meeting is a plan, not an outcome. A board that meets to consider fund raising may approve it, change it or decide against it, and companies do reschedule their own meetings. Once a decision is taken and carries an ex-date, it appears on the corporate actions calendar instead. Filter by date range or agenda, search for a company by name or symbol, or sign in to narrow the calendar to your own watchlist or portfolio.